Course Description:
The 340B Program is complicated and recent issues with drug manufacturers refusing to give 340B discounts to some/all contract pharmacies, as well as requests for additional information from the covered entities, has added to the complexity and resulted in a reduction in financial benefits for many covered entities.

Learning Objectives:

• Discuss recent changes in the 340B Program related to drug manufacturers.
  
• Discuss possible outcomes to the contract pharmacy issues.
  
• Identify recent issues identified in HRSA audits based on posted corrective action plans
• Explore current developments in Washington, DC to address the contract pharmacy issue.

Facilitator:
Renee Gravalin, CPA, Partner | Eide Bailly
Renee Gravalin has over 33 years of accounting and auditing experience in the health care industry. She is a former member of the American Institute of Certified Public Accountants Health Care Expert Panel as well as a current member of Eide Bailly’s Technical Issues Committee – Health Care. In addition to the work Renee does related to audits and financial forecasts for health care organizations, Renee also supervises and conducts 340B Compliance Reviews to assist organizations in identifying areas of improvement and ensure compliance with the complicated 340B regulations.

Additional Information: This is a Group-Internet Based Webinar. No prerequisites or advanced preparation required. For information regarding refund, complaint and program cancellation policies, please contact Amy DeGeorge.